Vincerx Pharma, Inc. (VINC)
NASDAQ: VINC · Real-Time Price · USD
0.760
-0.330 (-30.27%)
At close: Mar 3, 2025, 4:00 PM
0.789
+0.029 (3.83%)
After-hours: Mar 3, 2025, 5:59 PM EST
Vincerx Pharma Stock Forecast
VINC's stock price has decreased by -99.12% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Vincerx Pharma stock has a target of 40, which predicts an increase of 5,162.47% from the current stock price of 0.76.
Analyst Consensus: Buy
* Price targets were last updated on Oct 8, 2024.
Analyst Ratings
The average analyst rating for Vincerx Pharma stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 1 | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Leerink Partners | Leerink Partners | Buy Maintains $80 → $40 | Buy | Maintains | $80 → $40 | +5,162.47% | Oct 8, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 9, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 1, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +13,056.16% | Sep 7, 2023 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $80 → $60 | Strong Buy | Maintains | $80 → $60 | +7,793.70% | Nov 17, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-15.50
from -37.71
EPS Next Year
-9.38
from -15.50
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | n/a | n/a | 231,000 |
Avg | n/a | n/a | 224,400 |
Low | n/a | n/a | 215,600 |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -15.54 | -6.72 | -0.60 |
Avg | -15.50 | -9.38 | -0.58 |
Low | -15.29 | -11.76 | -0.56 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.